Cargando…
Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)
OBJECTIVE: Acute respiratory tract infections caused by Streptococcus pneumoniae are a leading cause of morbidity and mortality in young children and the elderly. In 2002, Alberta introduced a pneumococcal universal immunization program for children, using Pfizer’s Prevnar 7, a 7-valent pneumococcal...
Autores principales: | Waye, Arianna, Chuck, Anderson W., Jacobs, Philip, Tyrrell, Gregory, Kellner, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883192/ https://www.ncbi.nlm.nih.gov/pubmed/27747768 http://dx.doi.org/10.1007/s40801-015-0024-7 |
Ejemplares similares
-
Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
por: Waye, Arianna, et al.
Publicado: (2015) -
Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012) -
Whole-Genome Analysis of Streptococcus pneumoniae Serotype 4 Causing Outbreak of Invasive Pneumococcal Disease, Alberta, Canada
por: Kellner, James D., et al.
Publicado: (2021) -
Determination of Pneumococcal Serotypes in Meningitis Cases in Niger, 2003–2011
por: Collard, Jean-Marc, et al.
Publicado: (2013) -
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)